Intrathecal baclofen: Its effect on symptoms and activities of daily living in severe spasticity due to spinal cord injuries: A pilot study

Indian Journal of Orthopaedics

Volumn 43, Issue 1, 2009, Pages 46-49

  Jagatsinh, Yogendrasinh ^a,b  

^a Specialist Registrar General Surgery   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Activities of daily living; Intrathecal baclofen; Spasticity; Spinal cord injury

Indexed keywords

EID: 60049085160     PISSN: 00195413     EISSN: 19983727     Source Type: Journal    
DOI: 10.4103/0019-5413.45323     Document Type: Article

References (30)

1. Feldman RG, Young RR, Koella WP, Lance JW. Symposium synopsis: Spasticity-Disordered motor control. Chicago: Year Book Medical Publishers; 1980. p. 485.
2. Corston RN, Johnson F, Goodwin-Austen RB. The assessment of drug treatment of spastic gait. JNeurol Neurosurg Psychiatry 1981;44:1035-9.
3. Price GW, Wilkin GP, Turnbull MJ, Bowery NG. Are baclofen sensitive GABA-B receptors present on primary afferent terminal of the spinal cord. Nature 1984;307:71-4.
4. Loubser FG, Narayan RK, Sandin KJ, Donovan WH, Russell KD. Continuous infusion of intrathecal baclofen: long term effects on spasticity in spinal cord injury. Paraplegia 1991;29:48-64.
5. Medtronic implantable infusion pump-8615. Medtronic Inc, Neurologic Division, Minneapolis, MN 55440-9087.
6. Mahoney R, Barthel D. Functional Evaluation: the Barthel Index. Maryland State Med J1965;14:56-61.
7. Wright J The FIM & trade. The Center for Outcome Measurement in Brain Injury. 2000 http://www.tbims.org/combi/FIM. [accessed on 27th Nov 2008].
8. Catz A, Itzkovich M, Agranov E, Ring H, Tamir A. SCIM-spinal cord independence measure: Anew disability scale for patients with spinal cord lesions. Spinal Cord 1997;35:850-6.
9. Teddy P, Jamous AR, Gardner B, Wang D, Silver J Complications of intrathecal baclofen delivery. Br JNeurosurg 1992;6:115-8.
10. Milan R, Dimitrijevic. Spasticity, Scientific basis of clinical neurology. New York: Churchill Livingstone; 1985. p. 108-15
11. Fiddoch G. The reflex functions of the completely divided spinal cord in man, compared with those associated with less severe lesions. Brain 1917;40:264-402.
12. Penn RD, Kroin JB Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1984;1:1078.
13. Cofey RJ, Cahill D, Steers W, Park TS, Ordia J, Meythaler J, et al. Intrathecal baclofen for intractable spasticity of spinal origin: Results for long-term multi-centre study. JNeurosurg 1993;78:226-32.
14. Lazorthes Y. Chronic intrathecal administration of baclofen in treatment of severe spasticity. In: Muller H, Zierski J, Penn R, editors. Local spinal therapy of spasticity-Munich: Springer-Verlag 1988. p. 215-22.
15. Ochs GA, Struppler A, Meyerson BA, Linderoth B, Gybels J, Gardner BP, et al. Intrathecal baclofen for long-term treatment of spasticity: A multi-centre study. J Neural Neurosurg Psychiatry 1989;52:933-9.
16. Penn RD. Intrathecal baclofen for spasticity of spinal origin: Seven years experience. JNeurosurg 1992;77:236-40.
17. Zierski J, Muller H, Dralle D, Wurdinger T. Implanted pump system for treatment of spasticity. Acta Neurochir Suppl 1998;43:94-9.
18. Saltuari K, Kronenberg M, Marosi MJ, Kofler M, Russegger L, Rifici C, et al. Long-term intrathecal baclofen treatment in supraspinal spasticity. Acta Neural 1992;14:195-207.
19. Frost F, Nanninga J, Penn R Savoy S, Wu Y. Intrathecal baclofen infusion: Effect on bladder management programme in patients with myelopathy. Am JPhys Rehabil 1989;68:112-5.
20. William D, Steers, Meythaler JM, Howarth C, Herrell D, Rark TS, Effects of acute bolus and chronic continuous intrathecal baclofen on genitourinary dysfunction due to spinal cord pathology. JUrol 1992;148:1849-55.
21. Hum JJ, Elhass EM. Intrathecal baclofen infusions in patients with spasticity and neurogenic bladder disease. World JUrolol 1991;9:99-104.
22. Nanninga JB, Frost F, Penn R Effects of intrathecal baclofen on bladder and sphincter function. J Urology 1989;142:101-5.
23. Pederson S, Arlien-Soberg P, Mai J The mode of action of the GABA derivative baclofen in human spasticity. Acta Neurol Stand 1994;50:665-80.
24. Bowrey NG, Price GW, Hudson AL, Hill DR, Wilkin GP, Turnbull MJ GABA receptor multiplicity: Visualization of different receptor types in the mammalian CNS Neuropharmacology 1984;23:219-31.
25. Davies J. Selective depression of synaptic excitation in cat spinal neurons by baclofen: An iontophoretic study. Br J Pharmacol 1981;72:373-84.
26. Price GW, Wilkin GP, Turnbull MJ, Bowery NG Are baclofen sensitive GABA-B receptors present on primary afferent terminal of the spinal cord. Nature 1984;307:71-4.
27. Curtis DR, Malik R The differential effects of baclofen on segmental and descending excitation of spinal interneurons in the cat. Exp Brain Res 1985;58:333-7.
28. Henry JL Pharmacologic studies of baclofen in thespinal cord of the cat. In: Feldman RG, Young RR, Koella WP, editors. Spasticity: disordered motor control. London: Year Book Medical; 1980. p. 437-52.
29. Lat ash ML, Penn RD, Corcos DM, Gottlieb GL Short-term effects of intrathecal baclofen in spasticity. Exp Neurol 1989;103: 165-72.
30. Muller H, Zierski J, Dralle D, Börner U, Hoffmann O. The effects of intrathecal baclofen on electrical muscle activity in spasticity. JNeurol 1987;234:348-52.